

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 9.62574937 |
| 2 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 9.46396609 |
| 3 | regulation of translational termination (GO:0006449) | 9.42673828 |
| 4 | adult feeding behavior (GO:0008343) | 9.23524966 |
| 5 | regulation of acrosome reaction (GO:0060046) | 7.75075967 |
| 6 | regulation of protein glycosylation (GO:0060049) | 7.60610953 |
| 7 | positive regulation of cAMP-mediated signaling (GO:0043950) | 7.23080552 |
| 8 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 6.68738656 |
| 9 | sphingosine metabolic process (GO:0006670) | 6.59412651 |
| 10 | piRNA metabolic process (GO:0034587) | 6.43793367 |
| 11 | notochord development (GO:0030903) | 6.08959111 |
| 12 | regulation of female receptivity (GO:0045924) | 6.07674171 |
| 13 | diol metabolic process (GO:0034311) | 5.96441614 |
| 14 | DNA replication-dependent nucleosome organization (GO:0034723) | 5.88793101 |
| 15 | DNA replication-dependent nucleosome assembly (GO:0006335) | 5.88793101 |
| 16 | thrombin receptor signaling pathway (GO:0070493) | 5.77303378 |
| 17 | sphingoid metabolic process (GO:0046519) | 5.65970119 |
| 18 | glycerol ether metabolic process (GO:0006662) | 5.64558146 |
| 19 | female mating behavior (GO:0060180) | 5.28971952 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.26643372 |
| 21 | ether metabolic process (GO:0018904) | 5.20900977 |
| 22 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.18973735 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.14869799 |
| 24 | cellular response to ammonium ion (GO:0071242) | 4.87243097 |
| 25 | ncRNA catabolic process (GO:0034661) | 4.69942773 |
| 26 | pyrimidine dimer repair (GO:0006290) | 4.68779284 |
| 27 | regulation of cAMP-mediated signaling (GO:0043949) | 4.67614056 |
| 28 | mRNA cleavage (GO:0006379) | 4.64365172 |
| 29 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.58913540 |
| 30 | glomerular visceral epithelial cell development (GO:0072015) | 4.44602929 |
| 31 | cellular response to alkaloid (GO:0071312) | 4.07489927 |
| 32 | negative regulation of adenylate cyclase activity (GO:0007194) | 4.05826274 |
| 33 | negative regulation of cell-matrix adhesion (GO:0001953) | 4.03690053 |
| 34 | signal complex assembly (GO:0007172) | 4.01758493 |
| 35 | coenzyme catabolic process (GO:0009109) | 3.93333193 |
| 36 | glomerular epithelial cell development (GO:0072310) | 3.91499733 |
| 37 | negative regulation of cyclase activity (GO:0031280) | 3.85639324 |
| 38 | N-terminal protein amino acid acetylation (GO:0006474) | 3.81137936 |
| 39 | negative regulation of lyase activity (GO:0051350) | 3.79196759 |
| 40 | vitamin catabolic process (GO:0009111) | 3.75678280 |
| 41 | fat-soluble vitamin catabolic process (GO:0042363) | 3.75678280 |
| 42 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.73412308 |
| 43 | omega-hydroxylase P450 pathway (GO:0097267) | 3.62943287 |
| 44 | cornea development in camera-type eye (GO:0061303) | 3.56853659 |
| 45 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.55720376 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.54555804 |
| 47 | glycerophospholipid catabolic process (GO:0046475) | 3.49501650 |
| 48 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.37343821 |
| 49 | regulation of translational elongation (GO:0006448) | 3.35391537 |
| 50 | cell-cell junction maintenance (GO:0045217) | 3.27708754 |
| 51 | glycosphingolipid metabolic process (GO:0006687) | 3.26836852 |
| 52 | negative regulation of exocytosis (GO:0045920) | 3.25608480 |
| 53 | neuronal action potential (GO:0019228) | 3.22621661 |
| 54 | thyroid hormone generation (GO:0006590) | 3.22487314 |
| 55 | dopamine receptor signaling pathway (GO:0007212) | 3.17015054 |
| 56 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.13800415 |
| 57 | regulation of memory T cell differentiation (GO:0043380) | 3.10489276 |
| 58 | response to morphine (GO:0043278) | 3.03707647 |
| 59 | chemical homeostasis within a tissue (GO:0048875) | 3.03679520 |
| 60 | spermatid development (GO:0007286) | 3.02055563 |
| 61 | membrane depolarization during action potential (GO:0086010) | 3.01477700 |
| 62 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.98930154 |
| 63 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.98838291 |
| 64 | dopamine transport (GO:0015872) | 2.97892504 |
| 65 | positive regulation of fatty acid transport (GO:2000193) | 2.95271059 |
| 66 | left/right axis specification (GO:0070986) | 2.92840598 |
| 67 | thyroid hormone metabolic process (GO:0042403) | 2.91221014 |
| 68 | response to isoquinoline alkaloid (GO:0014072) | 2.90406996 |
| 69 | positive regulation of icosanoid secretion (GO:0032305) | 2.88693544 |
| 70 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.87130446 |
| 71 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.87045114 |
| 72 | detection of light stimulus involved in visual perception (GO:0050908) | 2.84920933 |
| 73 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.84920933 |
| 74 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.84297729 |
| 75 | lung secretory cell differentiation (GO:0061140) | 2.82335940 |
| 76 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.81492122 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 2.80966700 |
| 78 | regulation of odontogenesis (GO:0042481) | 2.79071287 |
| 79 | wound healing, spreading of epidermal cells (GO:0035313) | 2.75042760 |
| 80 | multicellular organismal reproductive behavior (GO:0033057) | 2.75016485 |
| 81 | glomerular basement membrane development (GO:0032836) | 2.74186778 |
| 82 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.72564649 |
| 83 | response to caffeine (GO:0031000) | 2.71557052 |
| 84 | sensory perception of pain (GO:0019233) | 2.69490290 |
| 85 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.67545089 |
| 86 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.67545089 |
| 87 | smooth muscle tissue development (GO:0048745) | 2.65073159 |
| 88 | steroid catabolic process (GO:0006706) | 2.65006743 |
| 89 | glycolipid metabolic process (GO:0006664) | 2.62149565 |
| 90 | negative regulation of cAMP metabolic process (GO:0030815) | 2.61675354 |
| 91 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 2.60529734 |
| 92 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.57412722 |
| 93 | positive regulation of cholesterol efflux (GO:0010875) | 2.57259611 |
| 94 | rhodopsin mediated signaling pathway (GO:0016056) | 2.56308701 |
| 95 | membrane lipid metabolic process (GO:0006643) | 2.54412051 |
| 96 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 14.9085511 |
| 97 | negative regulation of cAMP-mediated signaling (GO:0043951) | 12.7216895 |
| 98 | opioid receptor signaling pathway (GO:0038003) | 11.9190455 |
| 99 | behavioral response to ethanol (GO:0048149) | 10.1623344 |
| 100 | ether lipid metabolic process (GO:0046485) | 10.0276520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.74051801 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.68175801 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.06851160 |
| 4 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.67109480 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.31191928 |
| 6 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 3.25128228 |
| 7 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.25128228 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.22229386 |
| 9 | RXR_22108803_ChIP-Seq_LS180_Human | 2.57568243 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.55298286 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.25354193 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.19365406 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19070509 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.99023531 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95531456 |
| 16 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.90511288 |
| 17 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.90511288 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81742718 |
| 19 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.72242053 |
| 20 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.71519496 |
| 21 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.71137955 |
| 22 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.71137955 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65679815 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65300422 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.64898939 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63042772 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62384803 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.62378228 |
| 29 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62363772 |
| 30 | TCF4_23295773_ChIP-Seq_U87_Human | 1.62164084 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55621050 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.53655959 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53008563 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45365833 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45336034 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.45030333 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42813679 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39474211 |
| 39 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.38209650 |
| 40 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34480069 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34457709 |
| 42 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.34333294 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34222195 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32029660 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31680870 |
| 46 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.30744188 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29423235 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27431971 |
| 49 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.25308746 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24900285 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23320784 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22976488 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22969191 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21241129 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21082425 |
| 56 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.20779961 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18415828 |
| 58 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17492634 |
| 59 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.17245064 |
| 60 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16889588 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16697195 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16385045 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15668495 |
| 64 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12116050 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10908153 |
| 66 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10511076 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10347128 |
| 68 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10343590 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09165891 |
| 70 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.09053535 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09006507 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08921980 |
| 73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08621790 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08250534 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07860209 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07697829 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07309687 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07234798 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07010315 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04141146 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00677956 |
| 82 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00632418 |
| 83 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.00151936 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99482533 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98770735 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97473510 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95443192 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95059963 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93243725 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93064718 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.92976327 |
| 92 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92894861 |
| 93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92095041 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91106738 |
| 95 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91099082 |
| 96 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91064841 |
| 97 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90619453 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90593703 |
| 99 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90411178 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90344322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 6.72075749 |
| 2 | MP0009278_abnormal_bone_marrow | 6.65103054 |
| 3 | MP0002876_abnormal_thyroid_physiology | 4.99505716 |
| 4 | MP0001968_abnormal_touch/_nociception | 4.20021421 |
| 5 | MP0005360_urolithiasis | 4.12881191 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.42777110 |
| 7 | MP0003941_abnormal_skin_development | 2.79234449 |
| 8 | MP0000678_abnormal_parathyroid_gland | 2.78995534 |
| 9 | MP0001501_abnormal_sleep_pattern | 2.66023560 |
| 10 | MP0003880_abnormal_central_pattern | 2.59485411 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.53742990 |
| 12 | MP0000681_abnormal_thyroid_gland | 2.47915528 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.42178496 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.42178496 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.28134931 |
| 16 | MP0009764_decreased_sensitivity_to | 2.26591353 |
| 17 | MP0003045_fibrosis | 2.15163040 |
| 18 | MP0001664_abnormal_digestion | 2.05899792 |
| 19 | MP0003879_abnormal_hair_cell | 1.94955104 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 1.93339041 |
| 21 | MP0003136_yellow_coat_color | 1.89992860 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.87099568 |
| 23 | MP0003195_calcinosis | 1.79992397 |
| 24 | MP0002249_abnormal_larynx_morphology | 1.74077869 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.72050782 |
| 26 | MP0003638_abnormal_response/metabolism_ | 1.71765356 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.71635344 |
| 28 | MP0003959_abnormal_lean_body | 1.70696106 |
| 29 | MP0003646_muscle_fatigue | 1.70068970 |
| 30 | MP0008057_abnormal_DNA_replication | 1.67838432 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.66914067 |
| 32 | MP0003633_abnormal_nervous_system | 1.55716219 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.51751184 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.49604434 |
| 35 | MP0009745_abnormal_behavioral_response | 1.27011218 |
| 36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24734845 |
| 37 | MP0009046_muscle_twitch | 1.20426775 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.14903939 |
| 39 | MP0002272_abnormal_nervous_system | 1.13959557 |
| 40 | MP0001881_abnormal_mammary_gland | 1.13642297 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.13296345 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.11931910 |
| 43 | MP0005670_abnormal_white_adipose | 1.10596143 |
| 44 | MP0002971_abnormal_brown_adipose | 1.06324315 |
| 45 | MP0001270_distended_abdomen | 1.03290672 |
| 46 | MP0002796_impaired_skin_barrier | 1.00972400 |
| 47 | MP0005334_abnormal_fat_pad | 1.00283440 |
| 48 | MP0008004_abnormal_stomach_pH | 0.99872027 |
| 49 | MP0002168_other_aberrant_phenotype | 0.98676359 |
| 50 | MP0000230_abnormal_systemic_arterial | 0.98318404 |
| 51 | MP0002638_abnormal_pupillary_reflex | 0.97954915 |
| 52 | MP0001485_abnormal_pinna_reflex | 0.95910333 |
| 53 | MP0001486_abnormal_startle_reflex | 0.95111549 |
| 54 | MP0001970_abnormal_pain_threshold | 0.93463091 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 0.91712215 |
| 56 | MP0004858_abnormal_nervous_system | 0.90797168 |
| 57 | MP0004742_abnormal_vestibular_system | 0.88745604 |
| 58 | MP0003631_nervous_system_phenotype | 0.87724604 |
| 59 | MP0008775_abnormal_heart_ventricle | 0.86123063 |
| 60 | MP0003937_abnormal_limbs/digits/tail_de | 0.84484312 |
| 61 | MP0004130_abnormal_muscle_cell | 0.83544166 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 0.77870312 |
| 63 | MP0000372_irregular_coat_pigmentation | 0.76696674 |
| 64 | MP0005195_abnormal_posterior_eye | 0.74375150 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.73469175 |
| 66 | MP0008874_decreased_physiological_sensi | 0.73359337 |
| 67 | MP0000538_abnormal_urinary_bladder | 0.72371271 |
| 68 | MP0000049_abnormal_middle_ear | 0.72045690 |
| 69 | MP0000749_muscle_degeneration | 0.71634608 |
| 70 | MP0008872_abnormal_physiological_respon | 0.70503357 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.69324300 |
| 72 | MP0009672_abnormal_birth_weight | 0.68207404 |
| 73 | MP0005310_abnormal_salivary_gland | 0.67085110 |
| 74 | MP0002229_neurodegeneration | 0.65624863 |
| 75 | MP0003868_abnormal_feces_composition | 0.65033910 |
| 76 | MP0001324_abnormal_eye_pigmentation | 0.64801039 |
| 77 | MP0002928_abnormal_bile_duct | 0.62655956 |
| 78 | MP0001963_abnormal_hearing_physiology | 0.61820531 |
| 79 | MP0002557_abnormal_social/conspecific_i | 0.59959244 |
| 80 | MP0005452_abnormal_adipose_tissue | 0.59940781 |
| 81 | MP0010771_integument_phenotype | 0.59645924 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 0.59461341 |
| 83 | MP0002735_abnormal_chemical_nociception | 0.58391324 |
| 84 | MP0003635_abnormal_synaptic_transmissio | 0.57237373 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.56889198 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 0.56214430 |
| 87 | MP0002132_abnormal_respiratory_system | 0.54716842 |
| 88 | MP0004147_increased_porphyrin_level | 0.54147664 |
| 89 | MP0008058_abnormal_DNA_repair | 0.53153429 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.51874276 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.51806056 |
| 92 | MP0003936_abnormal_reproductive_system | 0.51641601 |
| 93 | MP0005395_other_phenotype | 0.51132508 |
| 94 | MP0000627_abnormal_mammary_gland | 0.51090593 |
| 95 | MP0002736_abnormal_nociception_after | 0.50148139 |
| 96 | MP0002108_abnormal_muscle_morphology | 0.48997257 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.48097580 |
| 98 | MP0002063_abnormal_learning/memory/cond | 0.47731941 |
| 99 | MP0000516_abnormal_urinary_system | 0.47479809 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.47479809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Volvulus (HP:0002580) | 7.27027603 |
| 2 | Intestinal atresia (HP:0011100) | 6.48738792 |
| 3 | Pancreatic islet-cell hyperplasia (HP:0004510) | 6.09192225 |
| 4 | Abnormality of the aortic arch (HP:0012303) | 5.62902135 |
| 5 | Broad alveolar ridges (HP:0000187) | 5.38028867 |
| 6 | Oligodontia (HP:0000677) | 5.12167298 |
| 7 | Large for gestational age (HP:0001520) | 5.09347543 |
| 8 | Thickened helices (HP:0000391) | 4.66368122 |
| 9 | Poor head control (HP:0002421) | 4.63839813 |
| 10 | Focal motor seizures (HP:0011153) | 4.30443263 |
| 11 | Agitation (HP:0000713) | 4.26580216 |
| 12 | Gaze-evoked nystagmus (HP:0000640) | 4.23479032 |
| 13 | Mesangial abnormality (HP:0001966) | 4.16793308 |
| 14 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.91398796 |
| 15 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.83573307 |
| 16 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.83573307 |
| 17 | Abnormality of the ileum (HP:0001549) | 3.38903758 |
| 18 | Tubular atrophy (HP:0000092) | 3.33999108 |
| 19 | Large eyes (HP:0001090) | 3.23868429 |
| 20 | Gastrointestinal atresia (HP:0002589) | 3.23321431 |
| 21 | Neonatal respiratory distress (HP:0002643) | 3.17355175 |
| 22 | Tented upper lip vermilion (HP:0010804) | 3.15845056 |
| 23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.12338440 |
| 24 | Hypoproteinemia (HP:0003075) | 3.07457073 |
| 25 | Optic nerve hypoplasia (HP:0000609) | 3.06160963 |
| 26 | Myositis (HP:0100614) | 2.91616037 |
| 27 | Chromsome breakage (HP:0040012) | 2.86945073 |
| 28 | Abnormality of macular pigmentation (HP:0008002) | 2.85943746 |
| 29 | Cerebellar dysplasia (HP:0007033) | 2.85146851 |
| 30 | Type II lissencephaly (HP:0007260) | 2.85078077 |
| 31 | Abnormal hair laboratory examination (HP:0003328) | 2.83694353 |
| 32 | Focal seizures (HP:0007359) | 2.83375000 |
| 33 | Congenital stationary night blindness (HP:0007642) | 2.81749941 |
| 34 | Hyperpituitarism (HP:0010514) | 2.81721877 |
| 35 | Orchitis (HP:0100796) | 2.73110300 |
| 36 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.69929096 |
| 37 | Poor speech (HP:0002465) | 2.66065627 |
| 38 | Abnormality of the alveolar ridges (HP:0006477) | 2.62280479 |
| 39 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.61500869 |
| 40 | Hyperthyroidism (HP:0000836) | 2.61099609 |
| 41 | Progressive inability to walk (HP:0002505) | 2.48455770 |
| 42 | Embryonal renal neoplasm (HP:0011794) | 2.46006246 |
| 43 | Severe visual impairment (HP:0001141) | 2.45558413 |
| 44 | Nonprogressive disorder (HP:0003680) | 2.36934742 |
| 45 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.34447373 |
| 46 | Broad-based gait (HP:0002136) | 2.34204505 |
| 47 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.33598679 |
| 48 | Hypoplasia of the fovea (HP:0007750) | 2.33598679 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.33277650 |
| 50 | Goiter (HP:0000853) | 2.32716240 |
| 51 | Increased corneal curvature (HP:0100692) | 2.32318903 |
| 52 | Keratoconus (HP:0000563) | 2.32318903 |
| 53 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.31732106 |
| 54 | Hypoplasia of the brainstem (HP:0002365) | 2.31732106 |
| 55 | Ectropion (HP:0000656) | 2.30142092 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.28673388 |
| 57 | Dysdiadochokinesis (HP:0002075) | 2.27453247 |
| 58 | Dialeptic seizures (HP:0011146) | 2.27258878 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.20350351 |
| 60 | Generalized tonic-clonic seizures (HP:0002069) | 2.19718058 |
| 61 | Long nose (HP:0003189) | 2.17084274 |
| 62 | Lissencephaly (HP:0001339) | 2.16869212 |
| 63 | Restlessness (HP:0000711) | 2.16740734 |
| 64 | Amelogenesis imperfecta (HP:0000705) | 2.16483438 |
| 65 | Pili torti (HP:0003777) | 2.16285017 |
| 66 | Impulsivity (HP:0100710) | 2.10544842 |
| 67 | Hypercortisolism (HP:0001578) | 2.04891516 |
| 68 | Thyroid-stimulating hormone excess (HP:0002925) | 13.8633761 |
| 69 | Hydroxyprolinuria (HP:0003080) | 1.99902530 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 1.99902530 |
| 71 | Pendular nystagmus (HP:0012043) | 1.98766813 |
| 72 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.94631823 |
| 73 | Cutaneous melanoma (HP:0012056) | 1.92217121 |
| 74 | Abnormality of the vitreous humor (HP:0004327) | 1.91616707 |
| 75 | Hypoplasia of the pons (HP:0012110) | 1.88306160 |
| 76 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.88110554 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 1.87527407 |
| 78 | Central scotoma (HP:0000603) | 1.87275851 |
| 79 | Poikiloderma (HP:0001029) | 1.85035657 |
| 80 | Hamartoma (HP:0010566) | 1.84747472 |
| 81 | Striae distensae (HP:0001065) | 1.81395177 |
| 82 | Hypohidrosis (HP:0000966) | 1.78864560 |
| 83 | Pigmentary retinal degeneration (HP:0001146) | 1.78777320 |
| 84 | Keratitis (HP:0000491) | 1.78376571 |
| 85 | Abnormality of the renal cortex (HP:0011035) | 1.76426897 |
| 86 | Abnormality of the fovea (HP:0000493) | 1.74399287 |
| 87 | Status epilepticus (HP:0002133) | 1.74370766 |
| 88 | Muscular dystrophy (HP:0003560) | 1.73057010 |
| 89 | Entropion (HP:0000621) | 1.71098583 |
| 90 | Abnormality of the pons (HP:0007361) | 1.70162957 |
| 91 | Epileptic encephalopathy (HP:0200134) | 1.68392622 |
| 92 | Adrenal overactivity (HP:0002717) | 1.66982897 |
| 93 | Cone-rod dystrophy (HP:0000548) | 1.65977978 |
| 94 | Inability to walk (HP:0002540) | 1.64203983 |
| 95 | Ileus (HP:0002595) | 1.62243777 |
| 96 | Abnormality of nail color (HP:0100643) | 1.62070986 |
| 97 | Scotoma (HP:0000575) | 1.61803432 |
| 98 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.60746249 |
| 99 | True hermaphroditism (HP:0010459) | 1.60682583 |
| 100 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.58274391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.15786654 |
| 2 | ERN1 | 4.22256512 |
| 3 | PINK1 | 3.49637135 |
| 4 | IRAK3 | 2.85329751 |
| 5 | ADRBK1 | 2.74718864 |
| 6 | PNCK | 2.69537979 |
| 7 | ZAK | 2.25974756 |
| 8 | ADRBK2 | 10.4222630 |
| 9 | TLK1 | 1.94209921 |
| 10 | CASK | 1.91838796 |
| 11 | PRKCG | 1.77991734 |
| 12 | IRAK1 | 1.71983142 |
| 13 | ACVR1B | 1.53804675 |
| 14 | PRKCE | 1.47628611 |
| 15 | MST4 | 1.46207604 |
| 16 | TYRO3 | 1.40046377 |
| 17 | DYRK3 | 1.34933960 |
| 18 | GRK1 | 1.31561432 |
| 19 | TGFBR1 | 1.27509911 |
| 20 | BMPR1B | 1.20681593 |
| 21 | STK38L | 1.19662634 |
| 22 | PRKCI | 1.16060152 |
| 23 | MAPK11 | 1.11029655 |
| 24 | CLK1 | 1.09376473 |
| 25 | CAMK1G | 1.07321073 |
| 26 | TNIK | 1.06850031 |
| 27 | PLK2 | 1.05690861 |
| 28 | WEE1 | 1.03192531 |
| 29 | FLT3 | 0.81149579 |
| 30 | MKNK2 | 0.80846592 |
| 31 | RIPK1 | 0.76035640 |
| 32 | CAMK2A | 0.75144046 |
| 33 | ERBB2 | 0.68105157 |
| 34 | MKNK1 | 0.68044946 |
| 35 | MAPKAPK5 | 0.64284407 |
| 36 | CDK12 | 0.63462702 |
| 37 | BRSK1 | 0.58943021 |
| 38 | STK3 | 0.58057910 |
| 39 | MELK | 0.54045055 |
| 40 | STK38 | 0.52867809 |
| 41 | GRK7 | 0.51563708 |
| 42 | STK10 | 0.51238050 |
| 43 | GRK5 | 0.49875207 |
| 44 | VRK1 | 0.49864577 |
| 45 | DAPK2 | 0.49002992 |
| 46 | DYRK1A | 0.47947271 |
| 47 | TAOK3 | 0.47900695 |
| 48 | PHKG1 | 0.46750122 |
| 49 | PHKG2 | 0.46750122 |
| 50 | CAMK1 | 0.46712257 |
| 51 | PIK3CA | 0.44119263 |
| 52 | CDC7 | 0.42996774 |
| 53 | PRKCB | 0.42392141 |
| 54 | OXSR1 | 0.42189704 |
| 55 | NEK9 | 0.41585096 |
| 56 | STK39 | 0.40980960 |
| 57 | SGK1 | 0.38694448 |
| 58 | BCKDK | 0.38070505 |
| 59 | RPS6KA3 | 0.35423849 |
| 60 | CSNK1E | 0.34783605 |
| 61 | PRKCA | 0.34698100 |
| 62 | TXK | 0.33894037 |
| 63 | WNK3 | 0.33661414 |
| 64 | MAPK1 | 0.33148645 |
| 65 | AKT1 | 0.31948546 |
| 66 | CSNK1A1 | 0.30046395 |
| 67 | WNK4 | 0.28552981 |
| 68 | RPS6KA5 | 0.28384888 |
| 69 | PDK2 | 0.28342224 |
| 70 | AURKB | 0.26642583 |
| 71 | ABL1 | 0.26606528 |
| 72 | GSK3B | 0.26505710 |
| 73 | CSNK2A2 | 0.25606786 |
| 74 | MAPK3 | 0.25230922 |
| 75 | MAPK14 | 0.24966596 |
| 76 | BRSK2 | 0.24209378 |
| 77 | FGFR2 | 0.24185551 |
| 78 | PRKAA1 | 0.23914563 |
| 79 | PTK2B | 0.23892953 |
| 80 | EPHA4 | 0.21456761 |
| 81 | EPHA2 | 0.20356193 |
| 82 | MARK3 | 0.19815697 |
| 83 | PRKACG | 0.19588908 |
| 84 | PRKACA | 0.19343013 |
| 85 | CSNK1A1L | 0.18738909 |
| 86 | TEC | 0.18493766 |
| 87 | KIT | 0.18409532 |
| 88 | PIK3CG | 0.16793666 |
| 89 | ATM | 0.16657160 |
| 90 | PKN1 | 0.16397181 |
| 91 | CDK1 | 0.15143739 |
| 92 | KDR | 0.14903192 |
| 93 | CSNK1G3 | 0.14399865 |
| 94 | AKT2 | 0.14389315 |
| 95 | CSNK2A1 | 0.13300816 |
| 96 | IKBKB | 0.12868759 |
| 97 | MAPK10 | 0.12800326 |
| 98 | CCNB1 | 0.12643836 |
| 99 | SIK2 | 0.11740662 |
| 100 | PRKDC | 0.11663628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 3.95529249 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.84667409 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.29121932 |
| 4 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.76333033 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.75226069 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.73008457 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.71286841 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.65198411 |
| 9 | ABC transporters_Homo sapiens_hsa02010 | 2.54246176 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.42222418 |
| 11 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.34426627 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31425103 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21409173 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.21401465 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.18253374 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.95281057 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.92663780 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86732287 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.71525775 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.63360812 |
| 21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.60545043 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.59223176 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57046849 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51591683 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48155009 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45450522 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.43987450 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.41797508 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33566962 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33183574 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27391083 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.26326121 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25556452 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22972272 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22010265 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21777703 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19069767 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.13177796 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09316846 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04381685 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04190265 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01857149 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.01138583 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95058891 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89627072 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88643653 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83960608 |
| 48 | Nicotine addiction_Homo sapiens_hsa05033 | 0.83924184 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 0.82822882 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81722721 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81660509 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79734741 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77032588 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76832883 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76103210 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75867190 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71916554 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69806314 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65755494 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65669745 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.65414545 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64932218 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64425867 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59538278 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59295051 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55626527 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.55000026 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54081656 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52272016 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50940090 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49191611 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49017497 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47046086 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45486089 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44677757 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42690675 |
| 77 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42420878 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41009443 |
| 79 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39751835 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39039264 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38260565 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37464963 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.37179183 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.36835452 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34676922 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32803604 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30596211 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.30389437 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29941458 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28343898 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27840467 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.27801324 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.27256767 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26944448 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25213557 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.24735329 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24357508 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.20753080 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.20275860 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.20268221 |

